FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES Stock

Certificat

DE000MG33XN3

Market Closed - Börse Stuttgart 15:52:58 2024-07-04 EDT
6.23 EUR -3.26% Intraday chart for FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES
Current month-12.38%
1 month-43.62%
Date Price Change
24-07-04 6.23 -3.26%
24-07-03 6.44 -6.26%
24-07-02 6.87 -0.15%
24-07-01 6.88 -3.23%
24-06-28 7.11 -1.52%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 03:52 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG33XN
ISINDE000MG33XN3
Date issued 2024-04-26
Strike 68.43 $
Maturity Unlimited
Parity 2.47 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.41
Lowest since issue 6.23
Spread 0.62
Spread %9.05%

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
85.51 USD
Average target price
109.7 USD
Spread / Average Target
+28.31%
Consensus